Salesforce Friends ...
Health Care: Drugs
Columbia Laboratories Inc. (CBRX: NASDAQ)
$0.68 0.00 | 0.00%
06/04/12 - 04:00 PM ET
Company Balance Sheet
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 10.11M | 21.63M | 14.76M | 12.50M |
| Receivables | 4.70M | 4.14M | 4.26M | 3.56M |
| Inventories | 3.64M | 2.59M | 2.53M | 2.38M |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 34.14M | 28.86M | 22.65M | 19.54M |
| Property, Plant & Equipment, Gross | 4.36M | 3.81M | 3.76M | 3.71M |
| Accumulated Depreciation & Depletion | 2.87M | 3.29M | 3.07M | 2.89M |
| Property, Plant & Equipment, Net | 1.48M | 518.54K | 691.48K | 821.86K |
| Intangibles | 0.00 | 0.00 | 18.77M | 23.82M |
| Other Non-Current Assets | 464.29K | 484.14K | 1.64M | 1.45M |
| Total Non-Current Assets | 1.95M | 1.00M | 21.11M | 26.08M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 36.08M | 29.86M | 43.76M | 45.62M |
| Accounts Payable | 3.53M | 5.39M | 3.66M | 2.09M |
| Short Term Debt | 0.00 | 0.00 | 144.90K | 168.03K |
| Other Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Liabilities | 6.64M | 26.86M | 8.40M | 7.23M |
| Long Term Debt | 0.00 | 13.47M | 48.20M | 43.20M |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 8.22M | 9.44M | 328.37K | 305.43K |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 8.82M | 23.51M | 49.13M | 44.28M |
| Total Liabilities | 15.45M | 50.37M | 57.52M | 51.52M |
| Preferred Stock Equity | 228.00 | 591.00 | 591.00 | 591.00 |
| Common Stock Equity | 20.63M | -20.51M | -13.77M | -5.89M |
| Common Par | 873.67K | 844.34K | 657.62K | 540.08K |
| Additional Paid In Capital | 278.06M | 260.60M | 242.64M | 228.69M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -258.28M | -278.81M | -256.98M | -235.11M |
| Treasury Stock | -125.38K | -3.35M | -280.81K | -189.23K |
| Other Equity Adjustments | 104.90K | 196.60K | 197.73K | 178.06K |
| Total Capitalization | 20.63M | -7.04M | 34.43M | 37.31M |
| Total Equity | 20.63M | -20.51M | -13.77M | -5.89M |
| Total Liabilities & Stock Equity | 36.08M | 29.86M | 43.76M | 45.62M |
| Total Common Shares Outstanding | 87.33M | 80.97M | 65.63M | 53.94M |
| Preferred Shares | 22.87K | 59.13K | 59.13K | 0.00 |
| Treasury Shares | 36.45K | 3.46M | 131.94K | 63.64K |
| Basic Weighted Shares Outstanding | 86.33M | 73.46M | 56.36M | 52.44M |
| Diluted Weighted Shares Outstanding | 92.55M | 73.46M | 56.36M | 52.44M |
| Number of Employees | 21 | 22 | 62 | 62 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with CBRX
- Portfolio NameUser Type
- UserMy Portfolio
- Contributor11 Stocks Under $4 With Upside
- Usermincronn Portfolio 1
- Usercscob Portfolio 1
- Userpharmer
- UserSUPRATRADE 2307070204
- UserSUPRATRADE VIRTUAL SKY
- Userstock fund
- UserBob700 Portfolio 1
- UserDunroamins
Latest CBRX Headlines from TheStreet
- A Classic Biotech Long Shot 04.05.12 | 09:04 am
- Columbia Stock Gaps Down On Today's Open (CBRX) 02.27.12 | 08:02 am
- These Drugs Stocks Will Win FDA Approval 02.16.12 | 12:02 pm
- Columbia Stock Soars (CBRX) 01.24.12 | 12:01 pm
- Columbia Stock Gaps Down On Today's Open (CBRX) 01.23.12 | 08:01 am
- Columbia Stock Gaps Up On Today's Open (CBRX) 01.18.12 | 08:01 am
- Columbia Laboratories Inc. Stock Upgraded (CBRX) 08.10.11 | 07:08 am
- 11 Stocks Under $4 With Upside: Analysts 05.11.11 | 12:05 pm
- Biotech Calendar: Key Dates for May 05.02.11 | 09:05 am
- Columbia Stock Falls On Unusually High Volume (CBRX) 04.06.11 | 02:04 pm
Press Releases for CBRX
- Columbia Laboratories Reports First Quarter 2012 Financial Results - Business Wire 05.04.12 | 06:05 am
- Columbia Laboratories Hires Cowen And Company To Assist In Evaluating Potential Strategic Transactions - Business Wire 03.13.12 | 06:03 am
- Columbia Laboratories Reports Fourth Quarter And Year-End 2011 Financial Results - Business Wire 03.08.12 | 06:03 am
- Columbia Laboratories Receives Nasdaq Minimum Bid Price Non-compliance Letter - Business Wire 03.06.12 | 04:03 pm
- Columbia Laboratories Announces 42% Workforce Reduction - Business Wire 03.01.12 | 04:03 pm
- Columbia Laboratories To Discuss Fourth Quarter And Year-End 2011 Financial Results On March 8, 2012, Conference Call - Business Wire 03.01.12 | 06:03 am
- Columbia Laboratories Will Present March 5th At Cowen And Company Health Care Conference - Business Wire 02.29.12 | 06:02 am
- Faruqi & Faruqi, LLP Announces Investigation Of Columbia Laboratories Inc. - PR Newswire 02.09.12 | 11:02 am
- The Law Firm Of Levi & Korsinsky Notifies Investors With Losses On Their Investment In Columbia Laboratories Inc. Of Class Action Lawsuit And The Deadline Of April 2, 2012 To Seek A Lead Plaintiff Position - Business Wire 02.02.12 | 02:02 pm
- Bronstein, Gewirtz & Grossman, LLC Investigates Columbia Laboratories, Inc. - Business Wire 01.23.12 | 10:01 am
Partner Headlines for CBRX
- Bio-Pharma Drug Approval Watch List: Final Results Plus One To Watch - Seeking Alpha 03.30.12 | 09:03 am
- 12 Healthcare Companies Expecting Major February Catalysts - Seeking Alpha 02.01.12 | 07:02 am
- Market Losers - Benzinga 01.23.12 | 01:01 pm
- Columbia Labs Plummet after Recommendation Denial by FDA - Benzinga 01.23.12 | 09:01 am
- FDA Advisory Committee Declines to Recommend Approval of Progesterone Vaginal Gel 8% for the Reduction of Risk of Preterm Birth in Women with Short Uterine Cervical Length - Benzinga 01.20.12 | 04:01 pm
- Watson Pharma and Columbia Labs Plunge on Proposed FDA Review - Benzinga 01.17.12 | 01:01 pm
- Columbia Laboratories and Watson Pharmaceuticals Confirm FDA Advisory Committee to Review Preterm Birth NDA - Benzinga 11.10.11 | 09:11 am
- Zacks #1 Rank Additions for Friday - Tale of the Tape - Zacks 09.16.11 | 09:09 am
- Watson to Market Antares' OAB Drug - Analyst Blog - Zacks 07.12.11 | 10:07 am
- Upcoming PDUFA Dates for Sub-$5 Stocks - Seeking Alpha 07.05.11 | 09:07 am
